Next, we measured the levels of M-CSF and RANKL, which mediate normal osteoclast differentiation, and those of pathological osteoclastogenic inflammatory IL1β and TNFα in the serum obtained from patients with multiple myeloma using ELISA. The gene discussed is IL1B; the disease is plasma cell myeloma.